The Supreme Court said Wednesday it will consider whether to restrict access to a widely used abortion drug — even in states where the procedure is still allowed.

The case concerns the drug mifepristone that — when coupled with another drug — is one of the most common abortion methods in the United States.

The decision means the conservative-leaning court will again wade into the abortion debate after overturning Roe v. Wade last year, altering the landscape of abortion rights nationwide and triggering more than half the states to outlaw or severely restrict the procedure.

  • Buelldozer@lemmy.today
    link
    fedilink
    arrow-up
    1
    ·
    10 months ago

    If it’s within their power and following their rules (good faith)

    That’s the issue before SCOTUS! It’s being claimed that the FDA didn’t follow its own procedure when relaxing the prescription and dispensing rules for mifepristone.

      • Buelldozer@lemmy.today
        link
        fedilink
        arrow-up
        1
        ·
        edit-2
        10 months ago

        Twenty years is too late.

        Yes, which is why I think SCOTUS didn’t grant a writ of Certiorari for it. The argument about mifepristone’s FDA approval is dead.